US 10226526
Vaccines for human papilloma virus and methods for using the same
granted A61KA61K2039/53A61K2039/54
Quick answer
US patent 10226526 (Vaccines for human papilloma virus and methods for using the same) held by Inovio Pharmaceuticals, Inc. expires Mon Mar 07 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Inovio Pharmaceuticals, Inc.
- Grant date
- Tue Mar 12 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 07 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 8
- CPC classes
- A61K, A61K2039/53, A61K2039/54, A61K2039/70, A61K39/12